What are the latest 5–10 authoritative guidelines on pleural effusion and their publication dates?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Latest Authoritative Guidelines on Pleural Effusion

Based on the available evidence, the most recent and authoritative guidelines on pleural effusion are the 2023 British Thoracic Society (BTS) Guideline for Pleural Disease and the 2024 European Respiratory Society (ERS) Statement on Benign Pleural Effusions in Adults 1, 2.

Identified Guidelines with Publication Dates

1. British Thoracic Society (BTS) Guideline for Pleural Disease (2023)

  • Published: July 11,2023
  • Journal: Thorax
  • Scope: Comprehensive guideline covering all aspects of pleural disease including:
    • Unilateral pleural effusion diagnostic pathways
    • Malignant pleural effusion management
    • Pleural infection treatment algorithms
    • Pneumothorax management
    • Light's criteria for transudate/exudate differentiation 1

2. European Respiratory Society (ERS) Statement on Benign Pleural Effusions in Adults (2024)

  • Published: 2024
  • Journal: European Respiratory Journal
  • Scope: Focused specifically on benign pleural effusions with emphasis on:
    • Diagnostic approach to categorizing transudates versus exudates
    • Use of Light's criteria and alternative tests
    • NT-BNP and albumin gradient testing
    • Management of heart failure-related effusions 2

3. American Thoracic Society (ATS) Guidelines (Referenced but not directly provided)

  • The evidence references ATS guidelines for malignant pleural effusion management, though the specific publication date is not provided in the available documents 3

Important Context

These two guidelines (BTS 2023 and ERS 2024) represent the most current, evidence-based recommendations for pleural effusion management. The BTS guideline is particularly comprehensive, providing detailed diagnostic and treatment algorithms for multiple pleural conditions, while the ERS statement offers focused guidance on the critical initial step of differentiating transudates from exudates.

The 2023 BTS guideline supersedes the previous 2003 BTS guideline, incorporating updated evidence on diagnostic accuracy, treatment modalities including indwelling pleural catheters, fibrinolytic therapy, and modern imaging techniques 1, 4.

References

2
Guideline

ers statement on benign pleural effusions in adults.

European Respiratory Journal, 2024

Related Questions

What are the differences between the previous and current pleural effusion guidelines regarding diagnostic and management recommendations, including what has changed, what remains unchanged, and what remains controversial?
What are the indications for draining a pleural effusion versus managing it clinically only?
What is the appropriate treatment for pleural effusion?
Can a pigtail (small‑bore) chest tube be used to drain pleural effusions?
What ICD‑10‑CM code is used for pleural effusion and which ICD‑10‑PCS code is used for thoracentesis?
In a person following a proper diet, what factors cause excessive sebum (oil) production?
What is the differential diagnosis for a 25-year-old man with pectus excavatum, generalized joint hypermobility, and gastrointestinal symptoms?
Which diet contributes to excess sebum production and oily skin?
What is the optimal sequence for taking vitamins to maximize their absorption?
How should folic acid be administered (dose, timing, and interactions)?
What are the differences between the previous and current pleural effusion guidelines regarding diagnostic and management recommendations, including what has changed, what remains unchanged, and what remains controversial?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.